| Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336) |
|---|
| 04/10/2013 | CN102010425B 1,4-disulfide-7-azaspiro [4,4] nonane-8-carboxylic acid derivative histone deacetylase inhibitor and application thereof |
| 04/10/2013 | CN101195599B 2,4,6-phenyl substituted cyclic ketoenols |
| 04/04/2013 | WO2013049263A1 Substituted bicyclic heteroaryl compounds |
| 04/04/2013 | WO2013047813A1 1,2,4-triazine-6-carboxamide derivative |
| 04/04/2013 | WO2013044865A1 Oxazolidinone antibiotics containing fused ring |
| 04/04/2013 | WO2013044371A1 Photochromic and electrochromic diarylcyclopentene derivatives as optical filters |
| 04/04/2013 | WO2013044362A1 Selected inhibitors of protein tyrosine kinase activity |
| 04/04/2013 | WO2013044361A1 Inhibitors of protein tyrosine kinase activity |
| 04/04/2013 | WO2013044360A1 Inhibitors of protein tyrosine kinase activity |
| 04/04/2013 | US20130085256 Fused thiophenes, methods of making fused thiophenes, and uses thereof |
| 04/04/2013 | US20130085154 Crystalline forms of prasugrel salts |
| 04/04/2013 | US20130085151 Heterocyclic compounds and their uses |
| 04/04/2013 | US20130085128 6-(4-Hydroxy-phenyl)-3-alkyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| 04/04/2013 | DE112011101447T5 Bicarbazol enthaltende Verbindungen für OLEDs Bicarbazol containing compounds for OLEDs |
| 04/04/2013 | CA2832149A1 Photochromic and electrochromic diarylcyclopentene derivatives |
| 04/03/2013 | EP2574610A1 Inhibitors of human immonodeficiency virus replication |
| 04/03/2013 | CN103025742A Methods of making fused thiophenes |
| 04/03/2013 | CN103025741A Crystalline forms of kinase inhibitors |
| 04/03/2013 | CN103025740A Inhibitors of protein tyrosine kinase activity and use thereof to treat ophthalmic disorders |
| 04/03/2013 | CN103025729A Evaporable organically semiconductive material and use thereof in an optoelectronic component |
| 04/03/2013 | CN103012428A 4-(five-membered heterocycle pyrimidin/substituted pyridine) amino-1H-3-pyrazolecarboxamide CDK (cyclin dependent kinase)/Aurora dual inhibitor and application thereof |
| 04/03/2013 | CN103012427A Prasugrel hydrochloride ethanol solvate and preparation method thereof |
| 04/02/2013 | CA2595544C Compounds having analgesic and/or immunostimulant activity |
| 04/02/2013 | CA2565683C Substituted azepine derivatives as serotonin receptor modulators |
| 04/02/2013 | CA2564085C Heterocyclic amide compound and use thereof as an mmp-13 inhibitor |
| 03/28/2013 | WO2013043192A1 Galactokinase inhibitors for the treatment and prevention of associated diseases and disorders |
| 03/28/2013 | WO2013042414A1 Dithienopyrrole compound, dye for photoelectric conversion element, semiconductor electrode employing same for photoelectric conversion element, and photoelectric conversion element |
| 03/28/2013 | WO2013041176A1 Carbazole derivatives for organic electroluminescence devices |
| 03/28/2013 | WO2013040647A1 Novel antimicrobial compounds |
| 03/28/2013 | WO2012172438A3 Compositions and methods for modulating a kinase |
| 03/28/2013 | WO2012149189A3 Novel photoactive polymers |
| 03/28/2013 | US20130079529 Organic compounds, process for preparing same and uses in electronics |
| 03/28/2013 | US20130079359 Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma |
| 03/28/2013 | US20130079341 Thieno (2, 3b) pyrazine compounds as b-raf inhibitors |
| 03/28/2013 | US20130079330 Fused Thiazole Derivatives as Kinase Inhibitors |
| 03/28/2013 | US20130074927 Highly-fluorescent and photo-stable chromophores for enhanced solar harvesting efficiency |
| 03/28/2013 | CA2849087A1 Carbazole derivatives for organic electroluminescent devices |
| 03/27/2013 | EP2573559A1 Modulation of chemosensory receptors and ligands associated |
| 03/27/2013 | EP2571888A1 Methods of making fused thiophenes |
| 03/27/2013 | EP2571887A1 Process for preparing dithiinetetracarboxydiimides |
| 03/27/2013 | EP2571886A2 Organic compounds, process for preparing same and uses in electronics |
| 03/27/2013 | EP2571875A1 Male contraceptive compositions and methods of use |
| 03/27/2013 | EP2571503A2 Compositions and methods for treating neoplasia, inflammatory disease and other disorders |
| 03/27/2013 | CN103003284A Method for producing dithiine tetracarboximides |
| 03/27/2013 | CN103003283A Crystalline forms of kinase inhibitors |
| 03/27/2013 | CN103003262A Nitrogenated aromatic heterocyclic ring derivative |
| 03/27/2013 | CN102993210A New thienopyridine compound |
| 03/27/2013 | CN102093385B Schiff base compounds as well as preparation method and application of Schiff base compounds |
| 03/27/2013 | CN101627028B Substituted diazepan compounds as orexin receptor antagonists |
| 03/26/2013 | US8404736 Heterocyclic amide derivatives as EP4 receptor antagonists |
| 03/26/2013 | US8404708 Dual NK1/NK3 receptor antagonists |
| 03/21/2013 | WO2013040442A1 Phased dosing of clopidogrel |
| 03/21/2013 | WO2013039842A1 Compounds having semiconducting properties and related compositions and devices |
| 03/21/2013 | WO2012154009A3 Thienopyrimidine derivatives, pharmaceutically acceptable salts thereof, method for preparing thienopyrimidine derivatives, and pharmaceutical composition containing thienopyrimidine derivatives as active ingredients for preventing or treating diabetes-related diseases |
| 03/21/2013 | WO2012153348A3 Process for preparation of prasugrel and its intermediates |
| 03/21/2013 | WO2012148185A3 Organic semiconductor compound, method for preparing same, and organic semiconductor device employing same |
| 03/21/2013 | US20130072523 Analogues for the treatment or prevention of flavivirus infections |
| 03/21/2013 | US20130072521 Thienopyridine ester derivative containing cyano group, preparation method, use and composition thereof |
| 03/21/2013 | US20130072492 Soluble guanylate cyclase activators |
| 03/21/2013 | US20130072482 Anti-inflammatory compound having inhibitory activity against multiple tyrosine kinases and pharmaceutical composition containing same |
| 03/21/2013 | US20130072473 Compounds for treating protein folding disorders |
| 03/21/2013 | US20130072449 Lysophosphatidic acid receptor antagonists |
| 03/21/2013 | US20130071352 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors |
| 03/21/2013 | US20130069049 Compound comprising a five-membered hetero ring, an organic electrical element using the same and a terminal thereof |
| 03/21/2013 | US20130069040 Organic nanofiber structure based on self-assembled organogel, organic nanofiber transistor using the same, and method of manufacturing the organic nanofiber transistor |
| 03/21/2013 | CA2848756A1 Phased dosing of clopidogrel |
| 03/20/2013 | EP2570417A1 Thienopyridine ester derivative containing nitrile, preparation method, use and composition thereof |
| 03/20/2013 | EP2569303A1 Substituted n-alkyl and n-acyl tetrahydro-isoquinoline derivatives, preparation and therapeutic use thereof |
| 03/20/2013 | EP2569298A1 Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments |
| 03/20/2013 | CN102985428A Semiconducting polymers |
| 03/20/2013 | CN102985426A Pyrazolo [1, 5A] pyrimidine and thieno [3, 2B] pyrimidine derivatives as IRAK4 modulators |
| 03/20/2013 | CN102977116A Amorphous prasugrel hydrogen sulfate and preparation method thereof |
| 03/20/2013 | CN102977115A Novel synthetic method of prasugrel free base |
| 03/20/2013 | CN101863899B Method for improving resolution yield of clopidogrel camphorsulfonate |
| 03/19/2013 | US8399659 Compounds and methods for inhibiting mitotic progression |
| 03/19/2013 | US8399479 Modulators of cystic fibrosis transmembrane conductance regulator |
| 03/19/2013 | US8399458 Compounds useful as protein kinase inhibitors |
| 03/19/2013 | US8399449 Fused heterocyclic derivative and use thereof |
| 03/19/2013 | CA2562406C Cyclic amine compound |
| 03/14/2013 | WO2010062171A3 Cc-1065 analogs and their conjugates |
| 03/14/2013 | US20130065919 Substituted n-alkyl and n-acyl tetrahydro-isoquinoline derivatives, preparation and therapeutic use thereof |
| 03/14/2013 | US20130065914 Halogen or cyano substituted thieno [2,3-d]pyrimidines having mnk1/mnk2 inhibiting activity for pharmaceutical compositions |
| 03/14/2013 | US20130065901 2-aminopyridine analogs as glucokinase activators |
| 03/14/2013 | US20130065879 Heteroaryl compounds and uses thereof |
| 03/14/2013 | US20130065849 Biphotonic photosensitizers, nanoparticles containing the same and their use as drugs |
| 03/14/2013 | US20130065842 COMPOUNDS AS RORyT MODULATORS AND USES THEREOF |
| 03/14/2013 | US20130065325 Zwitterionic reagents |
| 03/14/2013 | US20130062598 Compounds Having Semiconducting Properties and Related Compositions and Devices |
| 03/13/2013 | EP2566871A2 Process for the preparation of dithiine tetracarboxydiimides |
| 03/13/2013 | EP2566869A1 Pyridone and aza-pyridone compounds and methods of use |
| 03/13/2013 | EP2566848A1 Improved oligothiophenes |
| 03/13/2013 | CN102971327A Anti-inflammatory compound having inhibitory activity against multiple tyrosine kinases, and pharmaceutical composition containing same |
| 03/13/2013 | CN102964354A Thienoimidazole-like derivatives and applications thereof |
| 03/12/2013 | US8394993 Process for the preparation of pharmaceutical intermediates |
| 03/12/2013 | US8394790 Psychotropic agents having glutamate NMDA activity |
| 03/07/2013 | WO2013033310A1 Modulators of rev-erb |
| 03/07/2013 | WO2013032284A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 03/07/2013 | WO2013030150A1 6h-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepines |
| 03/07/2013 | US20130060037 Materials with aza-dibenzothiophene or aza-dibenzofuran core for pholed |
| 03/07/2013 | US20130059867 Salt of fused heterocyclic derivative and crystal thereof |